Australia markets closed

Context Therapeutics Inc. (CNTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3800-0.0100 (-0.72%)
At close: 04:00PM EDT
1.3700 -0.01 (-0.72%)
After hours: 06:16PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
17,783
17,783
7,091
3,805
1,642
Selling general and administrative
7,290
7,290
7,790
3,633
930.667
Total operating expenses
25,073
25,073
14,881
7,438
2,572
Operating income or loss
-25,073
-25,073
-14,881
-7,438
-2,572
Interest expense
-
-
-
64.24
661.224
Total other income/expenses net
-55.57
-55.57
-502.004
-2,955
9,878
Income before tax
-23,964
-23,964
-14,836
-10,457
6,644
Income from continuing operations
-23,964
-23,964
-14,836
-10,457
6,644
Net income
-23,964
-23,964
-14,836
-10,457
6,644
Net income available to common shareholders
-23,964
-23,964
-14,836
-10,457
1,071
Basic EPS
-1.30
-1.50
-0.93
-3.69
0.10
Diluted EPS
-1.30
-1.50
-0.93
-3.69
-0.80
Basic average shares
15,966
15,966
15,966
2,834
10,210
Diluted average shares
15,966
15,966
15,966
2,834
10,210